文献速递免疫规划卫生政策与健康促进

加拿大百日咳健康与经济负担的微观模拟研究

The health and economic burden of pertussis in Canada: A microsimulation study.
PubMed 文献 · Vaccine · 2019-10-01

本研究采用微观模拟模型,从医疗 payer 视角估算加拿大安大略省百日咳终身健康与经济负担。婴儿(<6月龄)每例平均损失0.58 QALY、费用22,768加元,成人仅损失0.05 QALY;

要点

  • 婴儿每例百日咳平均损失0.58 QALY,费用22,768加元,负担最重。

核心结论

  • 百日咳持续存在的健康与经济后果显著,需改进防控策略。

研究设计与样本

  • 基于文献参数的微观模拟模型,模拟百日咳自然史,采用医疗 payer 视角和终身时间范围。
  • 模型结果与无百日咳健康状态的模型比较,并行概率敏感性分析生成估计分布。

主要发现

  • 每例百日咳总体损失的生命年低,>4岁人群损失可忽略。
  • 婴儿(<6月龄)每例平均QALY损失最大(0.58),成人仅0.05。
  • 婴儿每例平均费用最高,为22,768加元(95%CI:21,144–23,406);老年人(65岁以上)费用回升至1920加元(95%CI:1800–2033)。

临床怎么用

  • 应优先保护婴儿(<6月龄)等高负担人群,强化百日咳防控措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite excellent vaccine coverage, pertussis persists in Canada, with high incidence during recent outbreaks and non-negligible incidence in non-outbreak years. While Canadian pertussis incidence is well-characterized, the full health and economic impact of pertussis have not been examined in Canada. We estimated age-specific life years (LYs) and quality-adjusted life years (QALYs) lost, and costs due to pertussis in Ontario, Canada, using a model-based approach. METHODS: We developed a microsimulation model to simulate pertussis natural history. Daily probabilities of pertussis complications, hospitalizations, and disease sequelae as well as utilities and costs for health states were literature-derived. A healthcare payer perspective was used with a lifetime time horizon. Model outcomes were compared to those from a model with no pertussis health states. Probabilistic sensitivity analyses were used to generate distributions for estimates. Economic burden was estimated by multiplying case cost estimates by annual age-specific incidence. RESULTS: Overall, LYs lost per pertussis case was low, with negligible LYs lost in those aged >4 years. Infants (<6 months) had the greatest mean QALY loss per case (0.58), while adults lost only 0.05 QALYs per case. Infants experienced the greatest mean cost per case of $22,768 (95% CI: 21,144-23,406). Case costs generally declined with age, but increased in seniors (aged 65+) with mean cost of $1920 (95% CI: 1800-2033). Based on historic age-specific incidence, pertussis costs the Ontario healthcare system approximately $7.6-$21.5 M annually. In total economic cost estimates with QALYs valued at 1xGDP (3xGDP) per capita, the net impact of pertussis in Ontario was estimated at $21.7-$66.5 M annually ($50.0-$156.3 M). For all of Canada, total economic costs were estimated at $79.6-$241.3 M ($187.5-$580.5 M) annually. CONCLUSION: The health and economic consequences of pertussis persistence are substantial and highlight the need for improved control strategies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. McGirr A, Fisman DN, Tuite AR, et al. The health and economic burden of pertussis in Canada: A microsimulation study. Vaccine. 2019. PMID: 31585727. doi:10.1016/j.vaccine.2019.09.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。